Abiopharma

🔍 Conrad Thomas (Director)

Company: Sonos Inc (SONO)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 20,414 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 364,179.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 10,748 shares of Common Stock at $16.59 per share (Direct)
  Date: 2026-08-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 353,431.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 20,414 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 443,101.00 | transaction_form_type: 4 | Footnotes: F2, F1, F4, F4

Footnotes:

• F1: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Person.
• F2: Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon vesting and settlement for no consideration.
• F3: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were withheld by the Issuer in accordance with the agreement governing the RSUs to satisfy federal and state tax withholding obligations of the Reporting Person resulting from the vesting and settlement of RSUs.
• F4: These RSUs were granted on July 22, 2025 (the "Grant Date") and, pursuant to a modified vesting schedule, vest as follows: 1) 1/4 of the shares subject to the RSUs vest on the anniversary of the Grant Date, and 2) 1/16 of the shares subject to the RSUs vest in equal installments on each quarterly anniversary date thereafter until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. The RSUs are subject to double-trigger acceleration.